Emergent BioSolutions Inc... (EBS)
NYSE: EBS
· Real-Time Price · USD
6.40
-0.10 (-1.54%)
At close: May 23, 2025, 3:59 PM
6.37
-0.41%
After-hours: May 23, 2025, 05:30 PM EDT
-1.54% (1D)
Bid | 6.37 |
Market Cap | 347.38M |
Revenue (ttm) | 960M |
Net Income (ttm) | -131.6M |
EPS (ttm) | -2.58 |
PE Ratio (ttm) | -2.48 |
Forward PE | 5.18 |
Analyst | Buy |
Ask | 6.45 |
Volume | 991,397 |
Avg. Volume (20D) | 1,340,295 |
Open | 6.29 |
Previous Close | 6.50 |
Day's Range | 6.24 - 6.44 |
52-Week Range | 4.02 - 15.10 |
Beta | 2.09 |
Analyst Forecast
According to 0 analyst ratings, the average rating for EBS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+34.18%
Emergent BioSolutions shares are trading higher af...
Unlock content with
Pro Subscription
2 months ago
-8.69%
Emergent BioSolutions shares are trading lower after the company reported worse-than-expected Q4 revenue results.

2 weeks ago · seekingalpha.com
Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call TranscriptEmergent BioSolutions Inc. (NYSE:EBS ) Q1 2025 Earnings Call May 7, 2025 5:00 PM ET Company Participants Frank Vargo - Vice President, Assistant Treasurer Joe Papa - President and Chief Executive Offi...

2 months ago · seekingalpha.com
Emergent BioSolutions Inc. (EBS) Q4 2024 Earnings Call TranscriptEmergent BioSolutions Inc. (NYSE:EBS ) Q4 2024 Earnings Conference Call March 3, 2025 6:00 AM ET Company Participants Frank Vargo - Assistant Treasurer Joseph Papa - President and Chief Executive Offi...